5-methylcytosine has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, T; Mochizuki, K; Oishi, N; Vuong, HG | 1 |
1 other study(ies) available for 5-methylcytosine and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations.
Topics: 5-Methylcytosine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Mutation; Promoter Regions, Genetic; Telomerase; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2020 |